Bococizumab is a novel anti-PCSK9 antibody effectively developed to combat hypercholesterolemia. This therapeutic agent interacts with the PCSK9 protein, a critical regulator of cholesterol concentrations. By https://gorillasocialwork.com/story26524537/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia